Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
June 17 Product: AstraZenecas Imfinzi Indication: Endometrial cancer Monday, the FDA granted approval for AstraZenecas Imfinzi, in combination with chemotherapy, to treat primary advanced or recurrent endometrial cancer that is mismatch repair (MMR) deficient
Regular checkups help identify any early signs of complications
A.DincerF.ThakkarB.Sahin-EfeA.et al (2016b)
Seek medical attention if you experience: Severe or persistent nausea and vomiting that prevents adequate fluid or food intake Signs of dehydration, including decreased urination, dark urine, dizziness, or extreme thirst Significant unintended weight loss beyond expected therapeutic effects Difficulty swallowing or persistent throat pain Symptoms suggestive of pancreatitis, such as severe abdominal pain radiating to the back (stop taking tirzepatide and seek urgent care) [1] Right upper abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Call 911 or seek emergency care immediately for: Signs of allergic reaction, including facial/throat swelling, difficulty breathing, or severe rash Severe abdominal pain with vomiting that prevents keeping down any fluids Additionally, if you have diabetes, report any new or worsening vision changes and maintain regular retinal screening appointments
